Hillsdale Investment Management »

Theravance Biopharma shares owned by Hillsdale Investment Management

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Hillsdale Investment Management from 13F filings

Historical chart of Hillsdale Investment Management investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Hillsdale Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Hillsdale Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.5M 311k 14.60
2020-06-30 $644k 31k 20.98

More positions owned by Hillsdale Investment Management

Rbc Cad (RY)
Cibc Cad (CM)
Tor Dom Bk Cad (TD)
Shopify Inc cl a (SHOP)
Bk Nova Cad (BNS)
Agnico (AEM)
Bank Of Montreal Cadcom (BMO)
Enbridge (ENB)
Enerflex (EFXT)
NVIDIA Corporation (NVDA)
Ssr Mining (SSRM)
Kinross Gold Corp (KGC)
Wheaton Precious Metals Corp (WPM)
Fortis (FTS)
Aris Mng Corp (ARMN)

View all positions for Hillsdale Investment Management

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
Newtyn Management
BlackRock
Irenic Capital Management
Vanguard Group
Park West Asset Management
D. E. Shaw & Co
Oasis Management
Acadian Asset Management
State Street Corporation
Geode Capital Management
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
Morgan Stanley

View all funds holding Theravance Biopharma